Matching articles for "Lindane"
Drugs for Sexually Transmitted Infections
The Medical Letter on Drugs and Therapeutics • June 27, 2022; (Issue 1653)
This article includes recommendations for management
of most sexually transmitted infections (STIs)
other than HIV and viral hepatitis. Some of the
indications and dosages recommended here have
not been...
This article includes recommendations for management
of most sexually transmitted infections (STIs)
other than HIV and viral hepatitis. Some of the
indications and dosages recommended here have
not been approved by the FDA (see Table 1).
Drugs for Head Lice
The Medical Letter on Drugs and Therapeutics • November 21, 2016; (Issue 1508)
Head lice infestation occurs in all age groups, but especially
in elementary school children. In most cases,
transmission occurs by head-to-head...
Head lice infestation occurs in all age groups, but especially
in elementary school children. In most cases,
transmission occurs by head-to-head contact.
Ivermectin (Sklice) Topical Lotion for Head Lice
The Medical Letter on Drugs and Therapeutics • August 6, 2012; (Issue 1396)
The FDA has approved the antiparasitic drug ivermectin
in a 0.5% lotion (Sklice – Sanofi Pasteur) as a
single-use topical treatment for head lice in patients ≥6
months old. Oral ivermectin (Stromectol...
The FDA has approved the antiparasitic drug ivermectin
in a 0.5% lotion (Sklice – Sanofi Pasteur) as a
single-use topical treatment for head lice in patients ≥6
months old. Oral ivermectin (Stromectol – Merck) is
effective for treatment of head lice resistant to other
therapies, but it has not been approved by the FDA for
this indication.
Benzyl Alcohol Lotion for Head Lice
The Medical Letter on Drugs and Therapeutics • July 27, 2009; (Issue 1317)
The FDA has approved benzyl alcohol lotion, 5% (Ulesfia Lotion - Sciele) for treatment of head lice in patients ≥6 months old. The active ingredient is 5% benzyl alcohol; the vehicle is 5% mineral...
The FDA has approved benzyl alcohol lotion, 5% (Ulesfia Lotion - Sciele) for treatment of head lice in patients ≥6 months old. The active ingredient is 5% benzyl alcohol; the vehicle is 5% mineral oil.
Drugs for Head Lice
The Medical Letter on Drugs and Therapeutics • August 15, 2005; (Issue 1215)
Head lice occur in all age groups, but especially in elementary school children during the winter months. Infestations are becoming more difficult to treat because of increasing resistance to the chemical...
Head lice occur in all age groups, but especially in elementary school children during the winter months. Infestations are becoming more difficult to treat because of increasing resistance to the chemical pediculicides commonly used, particularly those that are available over-the-counter (OTC).
Drugs for Parasitic Infections
The Medical Letter on Drugs and Therapeutics • August 16, 2004; (Issue 1189)
Parasitic infections are found throughout the world. With increasing travel, immigration, use of immunosuppressive drugs and the spread of AIDS, physicians anywhere may see infections caused by previously...
Parasitic infections are found throughout the world. With increasing travel, immigration, use of immunosuppressive drugs and the spread of AIDS, physicians anywhere may see infections caused by previously unfamiliar parasites. The table below lists first-choice and alternative drugs for most parasitic infections. The brand names and manufacturers of the drugs are listed in this article.
Malathion for the Treatment of Head Lice
The Medical Letter on Drugs and Therapeutics • August 13, 1999; (Issue 1059)
...
0.5% malathion in 78% isopropanol was recently approved by the FDA for treatment of head lice.
Drugs for Head Lice
The Medical Letter on Drugs and Therapeutics • January 19, 1997; (Issue 992)
Several readers have asked the Medical Letter to review the treatment of head lice, which apparently have become increasingly resistant to recommended drugs (KY Mumcuoglu, American Entomologist, Fall 1996,...
Several readers have asked the Medical Letter to review the treatment of head lice, which apparently have become increasingly resistant to recommended drugs (KY Mumcuoglu, American Entomologist, Fall 1996, page 175). Assays for drug resistance of head lice have not been standardized, however, and poor technique, such as not using a louse comb after treatment to remove lice and nits (eggs), may be responsible for some treatment failures. The last Medical Letter article on treatment of parasitic infections (vol. 37, page 99, November 10, 1995) recommended 1% permethrin (Nix) or 0.5% malathion (Prioderm; Ovide) as the drug of choice for treatment of head lice and pyrethrins with piperonyl butoxide (Rid, and others) as an alternative.
Malathion For Head Lice
The Medical Letter on Drugs and Therapeutics • December 15, 1989; (Issue 807)
Ovide Lotion (GenDerm), 0.5% malathion in 78% alcohol, was recently approved by the US Food and Drug Administration for treatment of head lice; it is available only by prescription. A previous formulation of...
Ovide Lotion (GenDerm), 0.5% malathion in 78% alcohol, was recently approved by the US Food and Drug Administration for treatment of head lice; it is available only by prescription. A previous formulation of malathion (Prioderm Lotion - Medical Letter, 25:30, 1986) was commercially unsuccessful in the USA and was withdrawn.